Optimization of Parameters of Subthalamic Nucleus Stimulation

Parkinson Disease Clinical Trial

Official title:

Optimization of Parameters of Subthalamic Nucleus Stimulation

Clinical Trial Details — Status: Withdrawn

Administrative data

• NCT number: NCT03496532
• Other study ID #: 2017-01832
• Status: Withdrawn
• Phase: N/A
• Start date: October 10, 2018
• Est. completion date: May 3, 2021

Study information

• Verified date: August 2021
• Source: University Hospital, Geneva
• Contact: n/a
• Is FDA regulated: No
• Study type: Interventional

Clinical Trial Summary

Deep brain stimulation of the subthalamic nucleus is an effective treatment for Parkinson's disease. The analysis of cerebral signals of the subthalamic nucleus by local field potentials, provides one of the main electrophysiological markers of the success of the stimulation. This marker can be used to evaluate new paradigms of stimulation. So far, little studied, the temporal characteristics of the stimulation are very important in the effectiveness of the stimulation of the subthalamic nucleus, in Parkinson's disease. The first objective (Study I) is to compare the effectiveness of the stimulation when it is applied with biphasic symmetrical pulses and when applied with the standard pulses applied so far. The second objective (Study II) is to see if, by applying pseudo-random time intervals between each stimulation pulse, if it would be possible to improve the efficiency and to limit the side effects of the stimulation. The third objective (Study III) is to evaluate the electrophysiological changes of the subthalamic nucleus caused by the general anesthesia, in the anticipation of the realization of the surgery of the stimulation of the subthalamic nucleus under general anesthesia.

Description:

Study I and II: Patients who participate undergo pulse generator change under sedation. Four sets of stimulation parameters will be compared. The efficacy of every set will be measured on induced changes in LFP recorded from the STN electrodes. LFP will be compared between before, during and right after each stimulation conditions. The stimulation order will be randomized. All other stimulation parameters will be the same (macrocontact with most beta-oscillations, 1 minute, 1.5mA) . Study III: Patients who participate undergo their first pulse generator implantation, performed under general anesthesia because of wire tunnelisation. The depth of anesthesia will be documented, recording the BIS spectral analysis index. The difference in spectral amplitude density of LFP, in particular in beta band oscillations will be correlated with the depth of anesthesia as measured with the BIS index at the time of 2 minutes recordings.

Recruitment information / eligibility

• Status: Withdrawn
• Enrollment: 0
• Est. completion date: May 3, 2021
• Est. primary completion date: May 3, 2021
• Accepts healthy volunteers: No
• Gender: All
• Age group: 18 Years and older

Eligibility

Inclusion Criteria:

• patients suffering from Parkinson's disease, who must undergo surgery for the replacement of their neurostimulator (under sedation) or for the first positioning of it
• capacity of discernment
• informed signed consent

Exclusion Criteria:

• Health considerations in regard to adding 13' in surgery room (e.g. pain or incomfort).

Related Conditions & MeSH terms

• Parkinson Disease

Intervention

Device:
• biphasic stimulation
Fixed 70Hz symmetrical biphasic pulses
• standard stimulation
Fixed 70Hz pseudo-monophasic pulses
• Uniform distribution
Uniform distribution 70Hz Biphasic pulses
• Poisson distribution
Poisson distribution 70Hz Biphasic pulses
• Recordings of LFP oscillations
Two minutes of recordings of LFP oscillations will be performed from the contacts of the implanted electrode. Recordings of the depth of anaesthesia (BIS) all along the measurements performed under general anaesthesia.The correlation between the depth of anaesthesia and the cerebral oscillations recorded at the site of subthalamic nucleus will be studied.

Locations

Country	Name	City	State
Switzerland	University of Geneva	Geneva

Sponsors (1)

Lead Sponsor	Collaborator
Colette Boex

Country where clinical trial is conducted

Switzerland, 

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Comparison of quantity of Beta oscillations after biphasic pulses vs standard monophasic pulses	% of changes in the energy of Beta oscillations	10 minutes per patient
Primary	Comparison of quantity of Beta oscillations after pseudo random (Poisson distribution) vs uniform distribution of pulse time intervals	% of changes in the energy of Beta oscillations	10 minutes per patient
Primary	Observe the evolution of Beta oscillations during deep anesthesia	Energy of Beta oscillations	2 minutes per patient